In females, L2-Cmu mAb treatment led to a slight, albeit significant reduction in red blood cells (RBCs), hemoglobin (Hb), hematocrit (Hct), white blood cells (WBCs), lymphocytes (Supplementary Table 2), and serum phosphorus (Supplementary Table 3), though most values, with the exception of WBCs, remained within the normal range, and were less severely affected than previously reported with Ganitumab in young CD1 mice 26
Yes volume pricing is available for research labs, universities, and bulk orders
Semaglutide isnt usually covered under most insurances, and can cost patients $1,000 a month or more for treatment
Never purchase products labeled as for research purposes only or not for human use as they may have unknown ingredients
This is still clearly a work in progress, though